Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

Pfeifer, H.; Cazzaniga, G.; van der Velden, V. H. J.; Cayuela, J. M.; Schäfer, B.; Spinelli, O.; Akiki, S.; Avigad, S.; Bendit, I.; Borg, K.; Cavé, H.; Elia, L.; Reshmi, S. C.; Gerrard, G.; Hayette, S.; Hermanson, M.; Juh, A.; Jurcek, T.; Chillón, M. C.; Homburg, C.; Martinelli, G.; Kairisto, V.; Lange, T.; Lion, T.; Mueller, M. C.; Pane, F.; Rai, L.; Damm-Welk, C.; Sacha, T.; Schnittger, S.; Touloumenidou, T.; Valerhaugen, H.; Vandenberghe, P.; Zuna, J.; Serve, H.; Herrmann, E.; Markovic, S.; van Dongen, J. J. M.; Ottmann, O. G.

doi:10.1038/s41375-020-0707-2

Download PDF

Correction
Published: 14 January 2020

Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

H. Pfeifer¹,
G. Cazzaniga²,
V. H. J. van der Velden³,
J. M. Cayuela⁴,
B. Schäfer⁵,
O. Spinelli ORCID: orcid.org/0000-0003-0374-1536⁶,
S. Akiki⁷,
S. Avigad⁸,
I. Bendit⁹,
K. Borg¹⁰,
H. Cavé¹¹,
L. Elia¹²,
S. C. Reshmi¹³,
G. Gerrard ORCID: orcid.org/0000-0002-4614-227X¹⁴,
S. Hayette¹⁵,
M. Hermanson¹⁶,
A. Juh¹⁷,
T. Jurcek¹⁸,
M. C. Chillón¹⁹,
C. Homburg²⁰,
G. Martinelli²¹,
V. Kairisto²²,
T. Lange²³,
T. Lion²⁴,
M. C. Mueller²⁵,
F. Pane²⁶,
L. Rai²⁷,
C. Damm-Welk²⁸,
T. Sacha²⁹,
S. Schnittger³⁰,
T. Touloumenidou³¹,
H. Valerhaugen³²,
P. Vandenberghe³³,
J. Zuna³⁴,
H. Serve¹,
E. Herrmann³⁵,
S. Markovic¹,
J. J. M. van Dongen^3,36^na1 &
…
O. G. Ottmann³⁷^na1

Leukemia volume 34, page 1970 (2020)Cite this article

1749 Accesses
1 Citations
1 Altmetric
Metrics details

Subjects

The Original Article was published on 11 March 2019

Correction to: Leukemia

https://doi.org/10.1038/s41375-019-0413-0

Since publication of the original article the authors noticed the affiliation for author G. Martinelli was incorrect. Their correct affiliation is Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy. This has now been corrected in the PDF and HTML versions of this article.

Author information

These authors contributed equally: J. J. M. van Dongen, O. G. Ottmann

Authors and Affiliations

Department of Medicine, Hematology/Oncology, Goethe-University, Frankfurt, Germany
H. Pfeifer, H. Serve & S. Markovic
Pediatric Clinic, University of Milan Bicocca, San Gerardo Hospital, Monza, Italy
G. Cazzaniga
Department of Immunology, Erasmus MC, University, Medical Center Rotterdam, Rotterdam, The Netherlands
V. H. J. van der Velden & J. J. M. van Dongen
Hematology Laboratory and EA3518, University Hospital Saint-Louis, University Paris Diderot, Paris, France
J. M. Cayuela
Kinderspital Zurich, Onkologie Diagnostik Labor, Zurich, Switzerland
B. Schäfer
Hematology and Bone Marrow Transplant Unit, ASST-Papa Giovanni XXIII, Bergamo, Italy
O. Spinelli
Regional Genetics Laboratory, Birmingham Women’s NHS Foundation Trust, Birmingham, UK
S. Akiki
Pediatric Hematology Oncology, Schneider Children’s Medical Center of Israel, Petah Tikva, Israel
S. Avigad
Division of Hematology and Hemotherapy, Medical School, University of Sao Paulo, Sao Paulo, Brazil
I. Bendit
Department of Diagnostic Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
K. Borg
Department of Genetic Biochemistry, Hopital Robert Debre, Paris, France
H. Cavé
Department of Hematology, Laboratory of Molecular Biology, University La Sapienza, Roma, Italy
L. Elia
Institute for Genomic Medicine, Nationwide Children’s Hospital and the Ohio State University, Columbus, OH, USA
S. C. Reshmi
Imperial Molecular Pathology, Centre for Hematology, Imperial College London, London, UK
G. Gerrard
Laboratory of Molecular Biology and UMR5239, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre Benite, Lyon, France
S. Hayette
Department of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden
M. Hermanson
Division of Pediatric Hematology/Oncology, Department of Pediatrics, National University Hospital, Singapore, Singapore
A. Juh
Department of Internal Medicine-Hematology and Oncology, Masaryk University and University Hospital Brno, Brno, Czech Republic
T. Jurcek
Department of Hematology, University Hospital of Salamanca (IBSAL) & Cancer Research Centre-IBMCC, (Salamanca University-CSIC), Salamanca, Spain
M. C. Chillón
Department of Experimental Immunhematology/Immuncytology, Sanquin Diagnostics, Amsterdam, The Netherlands
C. Homburg
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy
G. Martinelli
TYKSLAB, Laboratory of Molecular Genetics, Turku University Hospital, Turku, Finland
V. Kairisto
Abteilung fur Hamatologie und internistische Onkologie, Universitat Leipzig, Leipzig, Germany
T. Lange
Childrens Cancer Research Institute, Labdia Labordiagnostik and Medical University, Vienna, Austria
T. Lion
III. Medizinische Klinik, Medizinische Fakultat Mannheim der Universitat Heidelberg, Mannheim, Germany
M. C. Mueller
Azienda Ospedaliera Universitaria Federico II di Napoli Universita, Naples, Italy
F. Pane
Department of Hematology, Royal Free Campus, University College London, London, United Kingdom
L. Rai
Department of Pediatric Hematology and Oncology, University Hospital, Justus Liebig University Giessen, Giessen, Germany
C. Damm-Welk
Hematology Department, Jagiellonain University Krakow, Krakow, Poland
T. Sacha
MLL Munich Leukemia Laboratory, Max-Lebsche-Platz 31, Munich, Germany
S. Schnittger
Hematology Department and HCT Unit, G. Papanicolaou Hospital, Thessaloniki, Greece
T. Touloumenidou
Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, Oslo, Norway
H. Valerhaugen
Center for Human Genetics, University Hospital Leuven and KU Leuven, Leuven, Belgium
P. Vandenberghe
CLIP, Department of Paediatric Haematology and Oncology, 2nd Faculty of Medicine, Charles University and UH Motol, Prague, Czech Republic
J. Zuna
Institut fur Biostatistik und Mathematische Modellierung, Goethe Universitat, Frankfurt, Germany
E. Herrmann
Department of Immunohematology and Blood Transfusion, Leiden University Medical Centre, Leiden, The Netherlands
J. J. M. van Dongen
School of Medicine, Division of Cancer and Hematology, Cardiff University, Cardiff, UK
O. G. Ottmann

Authors

H. Pfeifer
View author publications
Search author on:PubMed Google Scholar
G. Cazzaniga
View author publications
Search author on:PubMed Google Scholar
V. H. J. van der Velden
View author publications
Search author on:PubMed Google Scholar
J. M. Cayuela
View author publications
Search author on:PubMed Google Scholar
B. Schäfer
View author publications
Search author on:PubMed Google Scholar
O. Spinelli
View author publications
Search author on:PubMed Google Scholar
S. Akiki
View author publications
Search author on:PubMed Google Scholar
S. Avigad
View author publications
Search author on:PubMed Google Scholar
I. Bendit
View author publications
Search author on:PubMed Google Scholar
K. Borg
View author publications
Search author on:PubMed Google Scholar
H. Cavé
View author publications
Search author on:PubMed Google Scholar
L. Elia
View author publications
Search author on:PubMed Google Scholar
S. C. Reshmi
View author publications
Search author on:PubMed Google Scholar
G. Gerrard
View author publications
Search author on:PubMed Google Scholar
S. Hayette
View author publications
Search author on:PubMed Google Scholar
M. Hermanson
View author publications
Search author on:PubMed Google Scholar
A. Juh
View author publications
Search author on:PubMed Google Scholar
T. Jurcek
View author publications
Search author on:PubMed Google Scholar
M. C. Chillón
View author publications
Search author on:PubMed Google Scholar
C. Homburg
View author publications
Search author on:PubMed Google Scholar
G. Martinelli
View author publications
Search author on:PubMed Google Scholar
V. Kairisto
View author publications
Search author on:PubMed Google Scholar
T. Lange
View author publications
Search author on:PubMed Google Scholar
T. Lion
View author publications
Search author on:PubMed Google Scholar
M. C. Mueller
View author publications
Search author on:PubMed Google Scholar
F. Pane
View author publications
Search author on:PubMed Google Scholar
L. Rai
View author publications
Search author on:PubMed Google Scholar
C. Damm-Welk
View author publications
Search author on:PubMed Google Scholar
T. Sacha
View author publications
Search author on:PubMed Google Scholar
S. Schnittger
View author publications
Search author on:PubMed Google Scholar
T. Touloumenidou
View author publications
Search author on:PubMed Google Scholar
H. Valerhaugen
View author publications
Search author on:PubMed Google Scholar
P. Vandenberghe
View author publications
Search author on:PubMed Google Scholar
J. Zuna
View author publications
Search author on:PubMed Google Scholar
H. Serve
View author publications
Search author on:PubMed Google Scholar
E. Herrmann
View author publications
Search author on:PubMed Google Scholar
S. Markovic
View author publications
Search author on:PubMed Google Scholar
J. J. M. van Dongen
View author publications
Search author on:PubMed Google Scholar
O. G. Ottmann
View author publications
Search author on:PubMed Google Scholar

Corresponding author

Correspondence to H. Pfeifer.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pfeifer, H., Cazzaniga, G., van der Velden, V.H.J. et al. Correction: Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1. Leukemia 34, 1970 (2020). https://doi.org/10.1038/s41375-020-0707-2

Download citation

Published: 14 January 2020
Issue date: July 2020
DOI: https://doi.org/10.1038/s41375-020-0707-2